Elevance Health Stock News

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announced that applications will open December 9, 2025, for its inaugural $5 million Patient Safety Prize. With a focus on improving health literacy, eliminating medication errors, and preventing patient falls, the Prize invites changemakers to submit transformational solutions that improve safety, advance quality of care, and enha...

First Eagle U.S. Fund A Shares (without sales charge*) posted a return of 7.55% in third quarter 2025. Materials and industrials were the leading contributors among equity sectors, while consumer staples detracted and real estate was flattish. The gold price continued to set new record nominal highs during the quarter.

If you're a parent, you've likely battled with your children over different options at dinner time. What kid wouldn't love to eat hot dogs for dinner every night and then wash it down with a milkshake?

Electronic Arts' shares outperformed the broader market during the period, driven by renewed investor confidence and momentum surrounding several high-profile product announcements. eBay's shares surged after reporting a strong second-quarter earnings report, bolstering confidence in the company's position in the marketplace. Elevance Health was the top underperformer over the period. Much of t...

Alphabet shares rose 38% during the quarter, which represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Elevance's share price declined by 16%, making it our largest negative contributor.

Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation if growth continues from 2026. The key risk remains a health benefit ratio above 90%, which will be closely monitored in upcoming quarters.

Annual premiums for U.S. families with employer-sponsored health insurance in 2025 rose 6% to nearly $27,000, reflecting higher spending on popular weight-loss treatments and other prescription drugs, according to a survey by health-policy organization KFF.

MINNEAPOLIS--(BUSINESS WIRE)-- #HistoSonics--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members.